Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia ...

The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.

UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best hot stocks to buy according to Wall Street analysts. In mid-June, UroGen ...

The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...

Beat bladder cancer with early detection! Expert insights reveal how a multidisciplinary approach can improve treatment outcomes in India. Learn more about effective care.

The FDA designates the TOBY Test as a breakthrough device, revolutionizing bladder cancer detection with a non-invasive, ...

Cambridge: AstraZeneca has received approval for Imfinzi (durvalumab) in the European Union (EU) for the treatment of adult ...

Bladder cancer may be scary but it will help to know that depending on the stage of cancer treatment will help control or ...

UK MHRA approves Serum Life Science Europe’s Anktiva to treat adult patients with non-muscle invasive bladder cancer: United Kingdom Monday, July 7, 2025, 12:00 Hrs [IST] The UK ...

Joseph Jacob, MD, discusses the promising impact of TAR-200.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Anktiva (nogapendekin alfa inbakicept) for adults with BCG-unresponsive non-muscle invasive bladder cancer, where ...

Multidisciplinary care, a collaborative approach where various healthcare disciplines come together, is essential for treating those with prostate cancer.